An imbalance in intestinal flora can reduce the production of SCFAs, decrease the secretion of GLP-1, and increase inflammation, leading to decreased insulin secretion and the destruction of islet β-cells, thereby increasing the risk of T1DM. This evidence concerns the gene INS and type 1 diabetes mellitus.